-
-
-
-
-
-
-
Clearmind Medicine signs research deal to study MEAI with tirzepatide
-
-
-
-
-
-
-
Clearmind Medicine Announces Filing of European Patent Application for Novel Psychedelic Compounds for the Treatment of PTSD
-
-
-
-
-
-
-
Clearmind Medicine gets safety board approval to continue alcohol disorder trial
-
-
-
-
-
-
-
Clearmind Medicine Files Patent Application in India for Next-Gen Psychedelic Compounds to Treat Mental Health Disorders
-
-
-
-
-
-
-
Clearmind Medicine Advances Recruitment for CMND-100 Trial's Third Cohort at Yale, Johns Hopkins and Tel Aviv Sites Following Recent Positive Topline Results
-
-
-
-
-
-
-
LDB Capital Corp. Announces Definitive Agreement for Proposed Qualifying Transaction with Eventer Technologies Ltd.
-
-
-
-
-
-
-
Clearmind Medicine Enters into Development Agreement to Advance Intranasal Formulation for its Proprietary Non-Hallucinogenic Neuroplastogen MEAI
-
1,155,348 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

